Cargando…

Dental Caries Prevalence in Human Immunodeficiency Virus Infected Patients Receiving Highly Active Anti-Retroviral Therapy in Kermanshah, Iran

OBJECTIVE: Introduction of new approaches for the treatment of human immunodefi- ciency virus (HIV) infection such as anti-retroviral medicines has resulted in an in- crease in the life expectancy of HIV patient. Evaluating the dental health status as a part of their general health care is needed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaei-Soufi, Loghman, Davoodi, Poorandokht, Abdolsamadi, Hamid Reza, Jazaeri, Mina, Malekzadeh, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933441/
https://www.ncbi.nlm.nih.gov/pubmed/24518976
_version_ 1782304936818638848
author Rezaei-Soufi, Loghman
Davoodi, Poorandokht
Abdolsamadi, Hamid Reza
Jazaeri, Mina
Malekzadeh, Hossein
author_facet Rezaei-Soufi, Loghman
Davoodi, Poorandokht
Abdolsamadi, Hamid Reza
Jazaeri, Mina
Malekzadeh, Hossein
author_sort Rezaei-Soufi, Loghman
collection PubMed
description OBJECTIVE: Introduction of new approaches for the treatment of human immunodefi- ciency virus (HIV) infection such as anti-retroviral medicines has resulted in an in- crease in the life expectancy of HIV patient. Evaluating the dental health status as a part of their general health care is needed in order to improve the quality of life in these patients. The aim of this study was to compare the root and crown caries rate in HIV patients receiving highly active antiretroviral therapy (HAART) with that rate in HIV patients without treatment option. MATERIALS AND METHODS: This cross sectional study consisting of 100 individuals of both genders with human immunodeficiency virus were divided into two groups: i. group 1 (treat- ment group) including 50 patients with acquired immunodeficiency syndrome (AIDS) receiving HAART and ii. group 2 (control group) including 50 HIV infected patients not receiving HAART. Dental examinations were done by a dentist under suitable light using periodontal probe. For each participant, numbers of decay (D), missed (M), filled (F), Decayed missed and filled teeth (DMFT), decay surface (Ds), missed surface (Ms), filled surface (Fs), Decayed missed and filled surfaces (DMFS), and tooth and root caries were recorded. Data were analyzed using Chi-square test and independent t test using SPSS 13.0, while p-value of <0.05 was considered statistically significant in all analysis. RESULTS: The mean and standard deviation (SD) of decayed, missed and filled teeth of those who were on highly active antiretroviral therapy was 6.86 ± 3.57, 6.39 ± 6.06 and 1.89 ± 1.93, respectively. There was no significant difference between these values regarding to the treat- ment of patients. The mean and standard deviation of DMFT, DMFS and the number of de- cayed root surfaces were 15.14 ± 6.09, 56.79 ± 28.56, and 4.96 ± 2.89 in patients treated by anti-retroviral medicine which were not significantly different compared to those without this treatment. CONCLUSION: According to the results of the present study, highly active antiretroviral ther- apy could not be considered as a single factor for dental caries prevalence in HIV-infected patients. However, more research is recommended to evaluate the cariogenic potential of these medicines.
format Online
Article
Text
id pubmed-3933441
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Royan Institute
record_format MEDLINE/PubMed
spelling pubmed-39334412014-04-01 Dental Caries Prevalence in Human Immunodeficiency Virus Infected Patients Receiving Highly Active Anti-Retroviral Therapy in Kermanshah, Iran Rezaei-Soufi, Loghman Davoodi, Poorandokht Abdolsamadi, Hamid Reza Jazaeri, Mina Malekzadeh, Hossein Cell J Original Article OBJECTIVE: Introduction of new approaches for the treatment of human immunodefi- ciency virus (HIV) infection such as anti-retroviral medicines has resulted in an in- crease in the life expectancy of HIV patient. Evaluating the dental health status as a part of their general health care is needed in order to improve the quality of life in these patients. The aim of this study was to compare the root and crown caries rate in HIV patients receiving highly active antiretroviral therapy (HAART) with that rate in HIV patients without treatment option. MATERIALS AND METHODS: This cross sectional study consisting of 100 individuals of both genders with human immunodeficiency virus were divided into two groups: i. group 1 (treat- ment group) including 50 patients with acquired immunodeficiency syndrome (AIDS) receiving HAART and ii. group 2 (control group) including 50 HIV infected patients not receiving HAART. Dental examinations were done by a dentist under suitable light using periodontal probe. For each participant, numbers of decay (D), missed (M), filled (F), Decayed missed and filled teeth (DMFT), decay surface (Ds), missed surface (Ms), filled surface (Fs), Decayed missed and filled surfaces (DMFS), and tooth and root caries were recorded. Data were analyzed using Chi-square test and independent t test using SPSS 13.0, while p-value of <0.05 was considered statistically significant in all analysis. RESULTS: The mean and standard deviation (SD) of decayed, missed and filled teeth of those who were on highly active antiretroviral therapy was 6.86 ± 3.57, 6.39 ± 6.06 and 1.89 ± 1.93, respectively. There was no significant difference between these values regarding to the treat- ment of patients. The mean and standard deviation of DMFT, DMFS and the number of de- cayed root surfaces were 15.14 ± 6.09, 56.79 ± 28.56, and 4.96 ± 2.89 in patients treated by anti-retroviral medicine which were not significantly different compared to those without this treatment. CONCLUSION: According to the results of the present study, highly active antiretroviral ther- apy could not be considered as a single factor for dental caries prevalence in HIV-infected patients. However, more research is recommended to evaluate the cariogenic potential of these medicines. Royan Institute 2014 2014-02-03 /pmc/articles/PMC3933441/ /pubmed/24518976 Text en Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Rezaei-Soufi, Loghman
Davoodi, Poorandokht
Abdolsamadi, Hamid Reza
Jazaeri, Mina
Malekzadeh, Hossein
Dental Caries Prevalence in Human Immunodeficiency Virus Infected Patients Receiving Highly Active Anti-Retroviral Therapy in Kermanshah, Iran
title Dental Caries Prevalence in Human Immunodeficiency Virus Infected Patients Receiving Highly Active Anti-Retroviral Therapy in Kermanshah, Iran
title_full Dental Caries Prevalence in Human Immunodeficiency Virus Infected Patients Receiving Highly Active Anti-Retroviral Therapy in Kermanshah, Iran
title_fullStr Dental Caries Prevalence in Human Immunodeficiency Virus Infected Patients Receiving Highly Active Anti-Retroviral Therapy in Kermanshah, Iran
title_full_unstemmed Dental Caries Prevalence in Human Immunodeficiency Virus Infected Patients Receiving Highly Active Anti-Retroviral Therapy in Kermanshah, Iran
title_short Dental Caries Prevalence in Human Immunodeficiency Virus Infected Patients Receiving Highly Active Anti-Retroviral Therapy in Kermanshah, Iran
title_sort dental caries prevalence in human immunodeficiency virus infected patients receiving highly active anti-retroviral therapy in kermanshah, iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933441/
https://www.ncbi.nlm.nih.gov/pubmed/24518976
work_keys_str_mv AT rezaeisoufiloghman dentalcariesprevalenceinhumanimmunodeficiencyvirusinfectedpatientsreceivinghighlyactiveantiretroviraltherapyinkermanshahiran
AT davoodipoorandokht dentalcariesprevalenceinhumanimmunodeficiencyvirusinfectedpatientsreceivinghighlyactiveantiretroviraltherapyinkermanshahiran
AT abdolsamadihamidreza dentalcariesprevalenceinhumanimmunodeficiencyvirusinfectedpatientsreceivinghighlyactiveantiretroviraltherapyinkermanshahiran
AT jazaerimina dentalcariesprevalenceinhumanimmunodeficiencyvirusinfectedpatientsreceivinghighlyactiveantiretroviraltherapyinkermanshahiran
AT malekzadehhossein dentalcariesprevalenceinhumanimmunodeficiencyvirusinfectedpatientsreceivinghighlyactiveantiretroviraltherapyinkermanshahiran